Lifecore Biomedical, Inc. \De\ (LFCR) EPS (Basic) (2010 - 2025)
Lifecore Biomedical, Inc. \De\ (LFCR) posted quarterly EPS (Basic) of -$0.06 for Q2 2025, up 74.71% year-over-year from -$0.03 in Q2 2024, and up 86.1% quarter-over-quarter from -$0.42 in Q1 2025.
Lifecore Biomedical, Inc. \De\ (LFCR) EPS (Basic) (2010 - 2025) Analysis & Trends
Lifecore Biomedical, Inc. \De\'s EPS (Basic) history runs 16 years deep, the most recent figure standing at -$0.06 for Q2 2025.
- In Q2 2025, EPS (Basic) rose 74.71% year-over-year to -$0.06; the TTM figure through May 2025 stood at -$1.22 (down 251.54% YoY), while the FY2025 annual figure was -$1.27, down 423.18% from the prior year.
- EPS (Basic) for Q2 2025 stood at -$0.06, up from -$0.42 in the prior quarter.
- The five-year high for EPS (Basic) was $0.51 in Q1 2024, with the low at -$1.75 in Q2 2022.
- The 5-year median for EPS (Basic) is -$0.15 (2022), against an average of -$0.3.
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) slumped 2362.33% in 2022, then soared 483.73% in 2023.
- Lifecore Biomedical, Inc. \De\'s EPS (Basic) stood at -$1.56 in 2021, then soared by 92.21% to -$0.12 in 2022, then surged by 483.73% to $0.47 in 2023, then tumbled by 154.26% to -$0.25 in 2024, then soared by 76.79% to -$0.06 in 2025.
- Business Quant data shows LFCR's EPS (Basic) at -$0.06 in Q2 2025, -$0.42 in Q1 2025, and -$0.25 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| May 25, 2025 | -0.06 |
| Feb 23, 2025 | -0.42 |
| Nov 24, 2024 | -0.25 |
| Aug 25, 2024 | -0.53 |
| May 26, 2024 | -0.23 |
| Feb 25, 2024 | 0.51 |
| Nov 26, 2023 | 0.47 |
| Aug 27, 2023 | 0.06 |
| May 28, 2023 | -0.08 |
| Feb 26, 2023 | -0.83 |
| Nov 27, 2022 | -0.12 |
| Aug 28, 2022 | -0.14 |
| May 29, 2022 | -1.75 |
| Feb 27, 2022 | -0.22 |
| Nov 28, 2021 | -1.56 |
| Aug 29, 2021 | -0.04 |
| May 30, 2021 | -0.07 |
| Feb 28, 2021 | -0.15 |
| Nov 29, 2020 | -0.11 |
| Aug 30, 2020 | -0.08 |